F10 - coagulation factor X Gene

Also Known as FX; FXA

Species: Homo sapiens

Gene Type: protein coding

Gene ID: 2159

About F10

Cytogenetic location: 13q34 Genomic coordinates (GRCh38): 13:113,122,799-113,149,529 (from NCBI)

This gene has 7 transcripts (splice variants), 236 orthologues, 16 paralogues and is associated with 2 phenotypes. Broad expression in liver (RPKM 44.8), ovary (RPKM 13.4) and 16 other tissues.

Summary

This gene encodes the vitamin K-dependent coagulation factor X of the blood coagulation cascade. This factor undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form by the excision of the tripeptide RKR. Two chains of the factor are held together by 1 or more disulfide bonds; the light chain contains 2 EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the Other hemostatic serine proteases. The mature factor is activated by the cleavage of the activation peptide by factor IXa (in the intrisic pathway), or by Factor VIIa (in the extrinsic pathway). The activated factor then converts prothrombin to Thrombin in the presence of factor Va, Ca+2, and phospholipid during blood clotting. Mutations of this gene result in factor X deficiency, a hemorrhagic condition of variable severity. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing to generate mature polypeptides. [provided by RefSeq, Aug 2015]

F10 Products (3)

mRNA	Protein	Name
NM_000504.4	NP_000495.1	coagulation factor X isoform 1 preproprotein
NM_001312674.2	NP_001299603.1	coagulation factor X isoform 2 precursor
NM_001312675.2	NP_001299604.1	coagulation factor X isoform 3 precursor

Gene Ontology

Molecular Function
Biological Process

Molecular Function GO Annotation	Evidence	Références	Source
enables phospholipid binding	IDA IDA: Inferred from direct assay	17469850	GOA
enables protein binding	IPI IPI: Inferred from physical interaction	6323392	GOA
enables serine-type endopeptidase activity	IDA IDA: Inferred from direct assay	17469850	GOA
enables serine-type endopeptidase activity	IMP IMP: Inferred from mutant phenotype	12574802	GOA

Biological Process GO Annotation	Evidence	Références	Source
involved in positive regulation of TOR signaling	IDA IDA: Inferred from direct assay	18612547	GOA

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

F10 Protein Structure

Gla

EGF

FXa_inhibition

Trypsin

0
100
200
300
400
488 a.a.

Protein Preferred Names	Protein Names
coagulation factor X	Stuart-Prower factor

F10 Protein-protein interaction Information

Type	Protein Name	Protein ID	Interactor	Interactor Species	Interactor ID	Detection Method	Références
Intra	F10	P00742	NOTCH2NLC	Homo sapiens	P0DPK4	Y2H Array	32296183
Intra	F10	P00742	NOTCH2NLC	Homo sapiens	P0DPK4	Validated Y2H	32296183
Intra	F10	P00742	NOTCH2NLC	Homo sapiens	P0DPK4	Y2H Prey Pooling	32296183
Intra	F10	P00742	UBQLN2	Homo sapiens	Q9UHD9	Y2H Prey Pooling	32296183
Intra	F10	P00742	UBQLN2	Homo sapiens	Q9UHD9	Validated Y2H	32296183
Intra	F10	P00742	UBQLN2	Homo sapiens	Q9UHD9	Y2H Array	32296183

Cross: Cross-species interaction Intra: Intraspecies interaction

Recombinant F10 Proteins

Cat. No.	Nom du produit	Accession	Pureté
HY-P7860	Coagulation Factor X/F10 Protein, Human (HEK293, Fc)	P00742 (N32-K488)	≥ 90%, as determined by reducing SDS-PAGE.

F10 Anticorps

Cat. No.	Nom du produit	Application	Reactivity
HY-P81604	Factor X Antibody (YA1349)	WB, IHC-P	Human

Related Diseases

Diseases	Alias
Factor X Deficiency	Stuart-Prower Factor Deficiency F10 Deficiency Congenital Stuart Factor Deficiency Factor X Deficiency, Congenital Congenital Factor X Deficiency Disease, Stuart-Prower Stuart Factor Deficiency, Congenital FA10D Factor 10 Deficiency Deficiency, Factor X Hereditary Factor X Deficiency Disease Deficiency Of Factor X Stuart Deficiency Disease Stuart Prower Deficiency Stuart-Prower Disease
Hemophilia B	Christmas Disease Factor Ix Deficiency F9 Deficiency HEMB Plasma Thromboplastin Component Deficiency Congenital Factor Ix Deficiency Mild Hemophilia B Severe Hemophilia B Congenital Factor Ix Disorder Deficiency, Functional Factor Ix Hem B Mild Congenital F9 Deficiency Mild Congenital Factor Ix Deficiency Moderate Hemophilia B Moderate Congenital F9 Deficiency Moderate Congenital Factor Ix Deficiency Severe Congenital F9 Deficiency Severe Congenital Factor Ix Deficiency Bleeding Disorder In Hemophilia B Carriers Congenital F9 Deficiency Recessive X-Linked Hemophilia B
Scott Syndrome	SCTS Bdplt7 Prothrombin Consumption Deficiency Bleeding Abnormality Due To Deficiency Of Platelet Binding Of Factor X Bleeding Disorder, Platelet-Type, 7 Prothrombin Conversion Defect, Familial Prothrombin Consumption Inhibitor, Familial Bleeding Abnormality Due To Deficiency Of Platelet Biding Of Factor X Familial Prothrombin Consumption Inhibitor Familial Prothrombin Conversion Defect Platelet-Type Bleeding Disorder 7 Platelet Factor X Receptor Deficiency Bleeding Disorder Platelet-Type 7 Prothrombin Consumption Inhibitor Familial Prothrombin Conversion Defect Familial
Hemorrhagic Disease	Hemorrhagic Disorders Hemorrhagic Diathesis Hemorrhagic Diseases Bleeding Tendency Acquired Coagulation Factor Inhibitor Disorder Acquired Inhibitor Of Coagulation Antithrombinaemia Antithromboplastinogenaemia Circulating Anticoagulant Disorder Haemorrhagic Disorder Due To Antithrombinaemia Haemorrhagic Disorder Due To Excess Administered Heparin Antithromboplastinaemia Haemorrhagic Disorder Due To Hyperheparinemia
Hemophilia A	Factor Viii Deficiency Haemophilia A Mild Hemophilia A HEMA Hemophilia, Classic Classic Hemophilia Factor 8 Deficiency Severe Hemophilia A Classical Hemophilia Hem A Hemophilia A, Congenital Mild Congenital F8 Deficiency Mild Congenital Factor Viii Deficiency Severe Congenital F8 Deficiency Severe Congenital Factor Viii Deficiency Moderate Hemophilia A Moderate Congenital F8 Deficiency Moderate Congenital Factor Viii Deficiency Bleeding Disorder In Hemophilia A Carriers Congenital F8 Deficiency Congenital Fviii Deficiency Congenital Factor Viii Deficiency Mild Hereditary Factor Viii Deficiency Disease Severe Hereditary Factor Viii Deficiency Disease Ahg - [Antihaemophilic Globulin] Deficiency Ahg - [Antihaemophilic Globulin] Deficiency Disease Congenital Factor Viii Disorder Sex-Linked Factor Viii Deficiency Antihaemophilic Globulin Deficiency Classic Haemophilia Familial Haemophilia Haemophilia Hereditary Haemophilia Subhaemophilia Haemophilia Nos
Carotid Artery Thrombosis
Hemarthrosis	Haemarthrosis Of Shoulder Joint Haemarthrosis Of The Ankle And Foot Haemarthrosis Of The Pelvic Region And Thigh Hemarthrosis Involving Ankle And Foot Hemarthrosis Involving Forearm Hemarthrosis Involving Hand Hemarthrosis Involving Lower Leg Hemarthrosis Involving Pelvic Region And Thigh Hemarthrosis Involving Shoulder Region Hemarthrosis Involving Upper Arm Hemarthrosis Of Ankle And/Or Foot Hemarthrosis Of Forearm Hemarthrosis Of Hand Hemarthrosis Of Lower Leg Hemarthrosis Of Shoulder Hemarthrosis Of Shoulder Region Hemarthrosis Of The Ankle And Foot Hemarthrosis Of The Ankle And/Or Foot Hemarthrosis Of The Forearm Hemarthrosis Of The Hand Hemarthrosis Of The Lower Leg Hemarthrosis Of The Pelvic Region And Thigh Hemarthrosis Of The Shoulder Region Hemarthrosis Of The Upper Arm Hemarthrosis Of Upper Arm
Antithrombin Iii Deficiency	Hereditary Antithrombin Deficiency Congenital Antithrombin Iii Deficiency Hereditary Thrombophilia Due To Congenital Antithrombin Deficiency AT3D Thrombophilia Due To Antithrombin Iii Deficiency Thph7 Hereditary Thrombophilia Due To Congenital Antithrombin 3 Deficiency Thrombophilia 7 Due To Antithrombin Iii Deficiency At Iii Deficiency Congenital At-Iii Deficiency Inherited Antithrombin Deficiency Antithrombin 3 Deficiency Antithrombin Deficiency Antithrombin-Iii Deficiency At-Iii Deficiency Thrombophilia Due To Antithrombin-Iii Deficiency
Myocardial Infarction	Heart Attack Myocardial Infarction, Susceptibility To Myocardial Infarction 1 Myocardial Infarction, Protection Against Myocardial Infarction, Decreased Susceptibility To Myocardial Infarction, Decreased Myocardial Infarct MCI1 Premature Myocardial Infarction Myocardial Infarction, Susceptibility To, Type 1
Thrombocytopenia	Low Platelet Count Low Platelets Decreased Platelets Platelet Dysfunction Nos
Hemophilia	Haemophilia Hemophilia, Familial Hemophilia, Hereditary Hemophilia A Hemophilia, Nos
Antiphospholipid Syndrome	Antiphospholipid Antibody Syndrome Hughes Syndrome Familial Antiphospholipid Syndrome Aps Lupus Anticoagulant, Familial Anti-Phospholipid Syndrome Apls Classic Apls Classic Antiphospholipid Syndrome Acromegaloid Facial Appearance Syndrome Anticardiolipin Syndrome
Thrombosis	Thrombosis Of Blood Vessel
Thrombophilia	Hypercoagulability State
Prothrombin Deficiency, Congenital	Dysprothrombinemia Hypoprothrombinemia Congenital Factor Ii Deficiency Prothrombin Deficiency Factor Ii Deficiency Congenital Prothrombin Deficiency FA2D Hypoprothrombinemias Inherited Factor Ii Deficiency Hereditary Factor Ii Deficiency Disease
Factor V Deficiency	Parahemophilia Labile Factor Deficiency Proaccelerin Deficiency Owren Disease Owren Parahemophilia Quebec Platelet Disorder Deficiency, Labile Hereditary Hypoproaccelerinaemia Owren'S Disease Congenital Factor V Deficiency FA5D Factor 5 Deficiency Deficiency, Factor V
Thrombophilia Due To Thrombin Defect	Venous Thromboembolism Venous Thrombosis Thrombophilia Due To Factor 2 Defect Thromboembolism THPH1 Thromboembolism, Susceptibility To Venous Thromboembolism, Susceptibility To Venous Thrombosis, Protection Against Prothrombin-Related Thrombophilia Hyperprothrombinemia Venous Thrombosis, Susceptibility To Thrombophilia 1 Due To Thrombin Defect F2-Related Thrombophilia Factor Ii-Related Thrombophilia Prothrombin 20210g>A Thrombophilia Prothrombin G20210a Thrombophilia Prothrombin Thrombophilia
Factor Vii Deficiency	Hypoproconvertinemia F7 Deficiency Congenital Proconvertin Deficiency Congenital Factor Vii Deficiency Factor 7 Deficiency Deficiency, Stable Proconvertin Deficiency Prothrombin Conversion Accelerator Deficiency Serum Prothrombin Conversion Accelerator Deficiency Proconvertin Deficiency, Congenital FA7D Stable Disease Deficiency, Factor Vii
Quebec Platelet Disorder	Factor V Quebec QPD Bdplt5 Bleeding Disorder, Platelet-Type, 5 Platelet-Type Bleeding Disorder 5 Bleeding Disorder Platelet-Type 5 Platelet Disorder, Quebec
Thrombophilia Due To Activated Protein C Resistance	Activated Protein C Resistance Apc Resistance THPH2 Thrombophilia Due To Deficiency Of Activated Protein C Cofactor Proc Cofactor Deficiency Pccf Deficiency Thrombophilia V Thrombophilia, Susceptibility To, Due To Factor V Leiden Thrombophilia Due To Factor V Leiden Thrombophilia 2 Due To Activated Protein C Resistance Thrombophilia, Susceptibility To, Due To Activated Protein C Resistance
Atrial Fibrillation	A-Fib Fibrillation, Atrial Af - [Atrial Fibrillation] Rapid Atrial Fibrillation A Fib - [Atrial Fibrillation]
Protein Z Deficiency
Protein S Deficiency	Protein S Deficiency Disease Hereditary Thrombophilia Due To Protein S Deficiency
Pulmonary Embolism	Pulmonary Artery Embolism Pulmonary Embolus Pulmonary Emboli
Afibrinogenemia, Congenital	Congenital Afibrinogenemia Afibrinogenemia Factor I Deficiency Familial Afibrinogenemia Hypofibrinogenemia, Congenital Fibrinogen Deficiency Afibrinogenemia Congenital CAFBN Congenital Hypofibrinogenemia Hypofibrinogenemia Complement Factor I Deficiency
Disseminated Intravascular Coagulation	Defibrination Syndrome Dic Diffuse Or Disseminated Intravascular Coagulation Fibrinolytic Purpura Consumption Coagulopathy Diffuse Intravascular Coagulation Dic - [Disseminated Intravascular Coagulation] Disseminated Intravascular Coagulopathy Fibrinolysis Nos Thrombolytic Purpura
Glanzmann Thrombasthenia 1	Glanzmann Thrombasthenia Thrombasthenia Of Glanzmann And Naegeli Glanzmann'S Thrombasthenia Bdplt2 Platelet Glycoprotein Iib-Iiia Deficiency Deficiency Of Platelet Fibrinogen Receptor GT1 Gt Platelet Fibrinogen Receptor Deficiency Glycoprotein Complex Iib-Iiia Deficiency Deficiency Of Glycoprotein Complex Iib-Iiia Glycoprotein Iib/Iiia Defect Glanzmann Thrombasthenia, Type A Thrombasthenia Bleeding Disorder, Platelet-Type, 2 Gp Iib-Iiia Complex Deficiency Deficiency Of Gp Iib-Iiia Complex Platelet-Type Bleeding Disorder 2 Thrombocytasthenia Deficiency Of Gp 2b 3a Complex Diacyclothrombopathia 2b 3a Glanzmann Thrombasthenia Type A Platelet Fibrinogen Receptor, Deficiency Of Platelet Glycoprotein 2b 3a Deficiency Glanzmann Disease Glanzmann-Naegeli Disorder Hereditary Hemorrhagic Thrombasthenia Hereditary Thrombasthenia Bleeding Disorder Platelet-Type 2
Blood Platelet Disease	Platelet Disorder Blood Platelet Disorders Thrombocytopathy Platelet Dysfunction Platelet Disorders Qualitative Platelet Deficiency
Puerperal Pulmonary Embolism	Obstetric Pulmonary Embolism
Acute Myocardial Infarction	Cardiac Attack Heart Attack
Viral Hepatitis	Animal Viral Hepatitis Hepatitis, Viral, Animal Human Viral Hepatitis Viral Hepatitis With Hepatic Coma
Pulmonary Artery Disease	Abnormality Of The Pulmonary Artery
Brachydactyly, Type D	Brachydactyly Type D BDD Stub Thumb Brachydactyly D
Factor Viii Deficiency	Autosomal Hemophilia A Hemophilia A Autosomal Factor Viii Deficiency Classic Hemophilia A Congenital Factor Viii Disorder Subhemophilia Factor 8 Deficiency, Congenital Factor Viii
Intracranial Thrombosis	Cerebral Thrombosis Thrombosis Of Cerebral Veins Cerebral Arterial Thrombosis
Gastroduodenal Crohn'S Disease	Upper Gi Crohn'S Disease
Post-Thrombotic Syndrome	Postphlebitic Syndrome Postthrombotic Syndrome Postphlebetic Syndrome With Inflammation Postphlebetic Syndrome With Ulcer Postphlebetic Syndrome With Ulcer And Inflammation Venous Stress Disorder
Prothrombin Deficiency	Factor Ii Deficiency Hypoprothrombinemia Dysprothrombinemia Deficiency, Prothrombin Inherited Factor Ii Deficiency Hereditary Factor Ii Deficiency Disease
Factor Xi Deficiency	Plasma Thromboplastin Antecedent Deficiency Rosenthal Syndrome Pta Deficiency Hemophilia C Rosenthal Factor Deficiency F11 Deficiency Congenital Factor Xi Deficiency Hereditary Factor Xi Deficiency Disease Haemophilia C Factor Xi Deficiency, Autosomal Dominant Rosenthal'S Disease Factor 11 Deficiency Factor Xi Factor Xi Deficiency, Autosomal Recessive Factor Xi Deficiency, Congenital FA11D Thromboplastin Antecedent Deficiency Pta - [Plasma Thromboplastin Antecedent] Deficiency Congenital Factor Xi Deficiency Disease Rosenthal Disease
Temporal Lobe Neoplasm	Neoplasm Of Temporal Lobe Malignant Neoplasm Of Temporal Lobe Tumor Of Temporal Lobe
Peroxisome Biogenesis Disorder 11a	PBD11A Peroxisome Biogenesis Disorder Complementation Group 13 PBD-CG13 Cg13 Pbd-Cgh Peroxisome Biogenesis Disorder Complementation Group H Peroxisome Biogenesis Disorder, Type 11a Peroxisome Biogenesis Disorder, Complementation Group 13
Blood Coagulation Disease	Blood Coagulation Disorders Coagulation Protein Disease Inherited Blood Coagulation Disease Postpartum Coagulation Defect Postpartum Coagulation Defect With Delivery Coagulation Protein Disorders Puerperal Coagulopathy
Stroke, Ischemic	Cerebral Infarction Stroke Ischemic Stroke Cerebrovascular Accident Cerebral Infarction, Susceptibility To Stroke, Ischemic, Susceptibility To Cerebral Infarct Ischemic Stroke, Susceptibility To Stroke, Susceptibility To Cva - Cerebral Infarction ISCHSTR Ischemic Cerebrovascular Accident
Heart Conduction Disease	Conduction Disorder Of The Heart Heart Rhythm Disease
Alpha-2-Plasmin Inhibitor Deficiency	Plasmin Inhibitor Deficiency Antiplasmin Deficiency Antiplasmin Defiency Anti-Plasmin Deficiency, Congenital Antiplasmin Deficiency, Congenital Congenital Alpha2-Antiplasmin Deficiency APLID Congenital Alpha2 Antiplasmin Deficiency
Lipoprotein Quantitative Trait Locus	Coronary Artery Disease Coronary Artery Anomaly Coronary Artery Disease, Susceptibility To Myocardial Ischemia Congenital Anomaly Of Coronary Artery Coronary Arteriosclerosis Coronary Disease Coronary Heart Disease Coronary Artery Disorder LPAQTL Lpa Deficiency, Congenital Coronary Artery Abnormality Coronary Artery Anomaly, Congenital Chd Coronary Syndrome Congenital Malformations Of Coronary Vessels Malformation Of Coronary Vessels Congenital Coronary Artery Anomaly Congenital Coronary Artery Deformity Congenital Coronary Artery Disorder Abnormal Coronary Artery Congenital Coronary Artery Malposition Congenital Coronary Disease Congenital Anomaly Of Coronary Arteries
Patent Foramen Ovale	Atrial Septal Defect Within Oval Fossa Foramen Ovale Patent Ostium Secundum Atrial Septal Defect Atrial Septal Defect, Ostium Secundum Type Foramen Ovale, Patent Defect, Patent Or Persistent, Ostium Secundum Ostium Secundum Type Atrial Septal Defect Persistent Ostium Secundum Asd Ostium Secundum Type Ostium Secundum Asd Osasd Asd, Ostium Secundum Type Pfo - [Patent Foramen Ovale] Open Foramen Ovale Open Oval Foramen Persistent Foramen Ovale Secundum Atrial Septal Defect

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Approval
Pre-clinical Phase

Approval

Bioactive Molecules (5)

Cat. No.	Nom du produit	Pureté	Rare Diseases
HY-B0984	Fendiline hydrochloride	99.78%	Unkown
HY-N0538	Xylitol	99.5%	Yes
HY-B0984A	Fendiline	99.41%	Unkown
HY-B0984R	Fendiline hydrochloride (Standard)	99.76%	Unkown
HY-107831	5-Acetylsalicylic acid	99.84%	Unkown

Pre-clinical Phase

Bioactive Molecules (73)

Cat. No.	Nom du produit	Effect	Pureté	Rare Diseases
HY-162275	JMJD1C-IN-1		99.96%	Unkown
HY-D0168	Orcinol		99.97%	Unkown
HY-N6069	Raspberry ketone glucoside	Activator	99.52%	Unkown
HY-151509	A2-Iso5-2DC18		99.96%	Unkown
HY-W001939	4-Acetylbenzoic acid		99.76%	Unkown
HY-W158030	2-Guanidinobezimidazole		95.74%	Unkown
HY-152263	HEMTAC CDK4/6 degrader 1		98.18%	Unkown
HY-W116007	Octamethylcyclotetrasiloxane	Inhibitor	99.86%	Unkown
HY-174830	GJ19	Inhibitor	98.02%	Unkown
HY-P2336A	CCZ01048 TFA		98.54%	Unkown
HY-179717	WZS0347	Degrader	99.06%	Unkown
HY-10615	A-620223	Inhibitor	98.84%	Unkown
HY-W004288	Methyl myristate		99.70%	Unkown
HY-W272217S	Octacosane-d58		99.05%	Unkown
HY-156085	LP23	Inhibitor	99.9%	Unkown
HY-172946	SD-2301	Degrader	/	Unkown
HY-W272217	Octacosane	Inhibitor	98.0%	Unkown
HY-157123	Tyrosinase-IN-18	Inhibitor	99.33%	Unkown
HY-169392	D5B	Inhibitor	98.94%	Unkown
HY-175370	PROTAC RIPK1 Degrader-1	Degrader	99.66%	Unkown
HY-175381	DeFer-2		98.25%	Unkown
HY-175714	STING agonist-46	Agonist	98.63%	Unkown
HY-W004288S	Methyl tetradecanoate-d27		99.0%	Unkown
HY-125762	Tyrosinase-IN-16	Inhibitor	98.0%	Unkown
HY-163120	Myosin-IN-1	Inhibitor	98.14%	Unkown
HY-RS19781	Il1f10 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-120241	Reticulol	Inhibitor	/	Unkown
HY-137052	Lycorine methiodide		/	Unkown
HY-142955	Dual photoCORM 1		/	Unkown
HY-146025	Antitumor agent-F10		/	Unkown
HY-149523	Anticancer agent 157		/	Unkown
HY-149950	Anticancer agent 106	Inducer	/	Unkown
HY-152233	Reverse transcriptase-IN-4	Inhibitor	/	Unkown
HY-155240	Tyrosinase-IN-13	Inhibitor	/	Unkown
HY-155681	SWS1	Inhibitor	/	Unkown
HY-156092	Antitumor photosensitizer-4		/	Unkown
HY-157323	HDAC6-IN-28		/	Unkown
HY-160021	RORγt agonist 4	Agonist	/	Unkown
HY-161971	Tyrosinase-IN-35	Inhibitor	/	Unkown
HY-162264	Tubulin polymerization/V-ATPase-IN-1		/	Unkown
HY-162766	Antitumor agent-184	Inducer	/	Unkown
HY-162962	IDO1/TDO-IN-7	Inhibitor	/	Unkown
HY-163534	PD-1/PD-L1-IN-43	Inhibitor	/	Unkown
HY-163596	PTPN2-IN-1	Inhibitor	/	Unkown
HY-168714	Microtubule inhibitor 12		/	Unkown
HY-172671	STING agonist-43	Agonist	/	Unkown
HY-174468	dPDL1-4		/	Unkown
HY-175014	LGT-1	Ligand	/	Unkown
HY-175369	PI3Kδ-IN-25	Inhibitor	/	Unkown
HY-179372	Tubulin polymerization-IN-84		99.59%	Unkown
HY-180159	Tubulin-IN-63		/	Unkown
HY-180825	Anticancer agent 292		/	Unkown
HY-N10802	6-O-Isobutyrylbritannilactone	Inhibitor	98.34%	Unkown
HY-N3773	Dodoviscin A	Inhibitor	/	Unkown
HY-N7587	Chlorophorin	Inhibitor	/	Unkown
HY-N9339	Norglaucine		/	Unkown
HY-P11026	DOTA-TMVP1446		/	Unkown
HY-P2336	CCZ01048		/	Unkown
HY-RS04624	F10 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS06719	IL1F10 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS10150	PCID2 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W267446	6-Methoxy-4-methylcoumarin	Activator	99.00%	Unkown
HY-W708886	Methyl-d3 tetradecanoate		/	Unkown
HY-W768347	Xylitol-13C5		/	Unkown
HY-134997	4-Oxo Docosahexaenoic Acid	Agonist	/	Unkown
HY-164473	DETD-35	Inhibitor	/	Unkown
HY-N14221	Eponemycin	Inhibitor	/	Unkown
HY-N14435	Pradimicin Q	Inhibitor	/	Unkown
HY-RS17793	F10 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS24261	F10 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS26278	Il1f10 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W001939R	4-Acetylbenzoic acid (Standard)		/	Unkown
HY-W587938	γ-Eudesmol	Inducer	/	Unkown

Inhibitory Antibodies (10)

Cat. No.	Nom du produit	Effect	Pureté	Rare Diseases
HY-P990263	Anti-Mouse CD73 Antibody (TY/23)	Inhibitor	95.00%	Unkown
HY-P990258	Anti-Mouse CLEC9A/CD370 Antibody (7H11)	Inhibitor	95%	Unkown
HY-P991447	Anti-VSIR/VISTA Antibody (SG7)	Inhibitor	98.07%	Unkown
HY-P990154	Anti-Mouse TIM-1/CD365 Antibody (3B3)	Inhibitor	/	Unkown
HY-P991464	IBI37G5	Inhibitor	/	Unkown
HY-P991468	IMM20324	Inhibitor	/	Unkown
HY-P991602	NI-1201	Inhibitor	/	Unkown
HY-P990804	Anti-Mouse NKG2D/CD314 Antibody (HMG2D)	Inhibitor	/	Unkown
HY-P990813	Anti-Mouse Nonclassical MHC Class I molecule Qa-1b Antibody (4C2.4A7.5H11)	Inhibitor	/	Unkown
HY-P991827	Anti-Mouse CTLA-4 Antibody (UC10-4F10-11)	Inhibitor	/	Unkown